-
Innovation Ranking
NewInnovation Ranking – Radius Health Inc
Radius Health Inc (Radius Health), formerly NuVios Inc, is a biopharmaceutical company that develops and markets novel medicines for bone health, and endocrine diseases. The company’s marketed product includes abaloparatide injection, which is indicated for the treatment of postmenopausal women with osteoporosis. Its pipeline encompasses abaloparatide subcutaneous injection (SC) for high risk of fracture in men with osteoporosis; abaloparatide transdermal (TD) patch for postmenopausal women with osteoporosis; elacestrant (RAD1901) for estrogen-receptor (ER)-positive breast cancer; and RAD140 as an oral treatment...
-
Company Insights
Innovation and Patenting activity of Radius Health Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Radius Health Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Angelman Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Angelman Syndrome - Drugs In Development, 2023’, provides an overview of the Angelman Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Angelman Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NVDX-3 in Bone Fracture
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NVDX-3 in Bone Fracture report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NVDX-3 in Bone Fracture Drug Details: NVD-X3 is under development for hard...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NVDX-3 in Degenerative Spondylolisthesis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NVDX-3 in Degenerative Spondylolisthesis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NVDX-3 in Degenerative Spondylolisthesis Drug Details: NVD-X3 is under development for hard...
-
Product Insights
Post Menopausal Osteoporosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Drugs In Development, 2023’, provides an overview of the Post Menopausal Osteoporosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post Menopausal Osteoporosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Thematic Analysis
NewGlobal Tech, Media, and Telecom (TMT) M&A Deals 2023 – Top Themes and Predictions – Thematic Intelligence
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 Theme and Predictions Report Overview Total M&A deal value in the technology, media, and telecom (TMT) sector declined 46% in 2023, compared to the previous year. Software and services accounted for over 48% share of the total M&A deal value in 2023. The ‘Global Tech, Media, And Telecom (TMT) M&A Deals 2023 Theme and Predictions Report’ analyzes the top disruptive themes that drove M&A activity in the technology, media, and telecom (TMT)...
-
Product Insights
Osteoporosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Osteoporosis - Drugs In Development, 2023’, provides an overview of the Osteoporosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Osteoporosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Osteoporosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Osteoporosis Clinical Trial Report Overview A total of 2,254 osteoporosis clinical trials were conducted as of December 2023. The osteoporosis clinical trial report provides a comprehensive understanding of the osteoporosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       Asia-Pacific ·       Europe ·       North America ·       ...
-
Case Studies
Bowery Farming – Success Case Study
"Success Case Study: Bowery Farming" is part of GlobalData's Success and Failure case study series. Bowery, a vertical farming company, was founded in 2015 by Irving Fain in New York, US. The company offers a range of fruits and vegetables produced in smart indoor farms near major cities within a 200-mile radius. As of 2022, total funding reached $647 million. Urban consumption represents over half of all US food demand, offering greater opportunities than rural areas. The use of social...